1,066.00
-1.5(-0.14%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5399
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Mr. Naresh Kapoor | Company Secretary & Compliance Officer | 6.86M | 1974 |
| Mr. Rajagopal Sankaraiah B.Sc., CA, F.C.A. | Advisor | 67.29M | 1959 |
| Mr. Arjun Shanker Bhartia | Joint MD & Director | 74.96M | 1987 |
| Mr. Priyavrat Bhartia MBA | MD & Director | 74.96M | 1976 |
| Mr. Prakash Chandra Bisht B.Com., CA | Executive Vice President of Group Accounts | 0 | 1964 |
| Mr. A. P. Srivastava B.A., BA | Senior Vice President of Corporate Affairs | 0 | 1946 |
| Mr. Arun Kumar Sharma B.Sc., BSc., C.A., CA | Chief Financial Officer & Group Treasurer | 0 | 1966 |
| Mr. Sanjay Gupta A.C.M.A., B.Com., L.L.B. | Executive Vice President & Head of Legal | 0 | 1966 |
| Mr. Shantanu Jha | Group Chief Human Resources Officer | 0 | N/A |
| Mr. Chandan Singh Sengar B.Sc., BSc., M.B.A., MBA | President of Life Science Chemicals | 0 | 1964 |
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and solid dosage formulations, as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is headquartered in Noida, India.
